Supplementary Material
Detection Technology and Clinical Applications of Serum Virological Products of Hepatitis B Virus (HBV) Infection
Preprint |
10.55415/deep-2023-0043.v1
This is not the most recent version. There is anewer
versionof this content available.
Abstract
Serum virological products of hepatitis B virus (HBV) infection, such as HBV DNA, HBV RNA, hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core-related antigen (HBcrAg), are important non-invasive indicators that are critical for the rapid diagnosis of the diseases. Improving the accuracy of these products is essential, and the development of corresponding detection technologies is pivotal in achieving this goal. The aim of this article is to provide a comprehensive and systematic overview of the life cycle of HBV, including the latest research progress. In addition, classical and novel methods for detecting HBV serum virological products with high accuracy are analyzed and compared, and their clinical applications are discussed. Ultimately, the goal of this article is to provide valuable insights and references for effectively monitoring chronic hepatitis B (CHB) infection.
Keywords
Subject Area
Version History
- 24 Jun 2023 10:37 Version 1
Scores
4
Rapid Rating Times:
1
· Level of
Quality: 4
· Level of Repeatability: 4
· Level of Innovation: 5
· Level of Impact: 3
Rapid Rating Times:
1
· Level of
Quality: 4· Level of Repeatability: 4
· Level of Innovation: 5
· Level of Impact: 3
*Each rating ranges from 0-5
Rapid Rating
Your professional field is different from the direction of this article.
Go Settings!
Not yet Peer Reviewed
The content is available
under CC BY-NC-ND 4.0
License CreativeCommons.org
The author(s) have declared they have no conflict of interest with regard to
this content
